Literature DB >> 31883097

Evaluation of Activation and Inflammatory Activity of Myeloid Cells During Pathogenic Human Coronavirus Infection.

Rudragouda Channappanavar1,2,3, Stanley Perlman4,5,6.   

Abstract

Innate immune cells play a vital role in mounting an effective host response to a variety of pathogen challenges. Myeloid cells such as neutrophils and monocyte-macrophages are major innate leukocytes that orchestrate protective immunity to viral lung infections. However, a dysregulated cytokine response can promote excessive infiltration and robust pro-inflammatory activity of neutrophils and monocyte-macrophages, leading to fatal disease. Following virus infection, the beneficial or deleterious role of infiltrating neutrophils and monocyte-macrophages is determined largely by their ability to secrete inflammatory cytokines and chemokines. A majority of studies use the total number of infiltrating cells and their activation status as measures to demonstrate their role during an infection. Consequently, the ability of neutrophils and Inflammatory Monocyte Macrophages (IMMs) to secrete inflammatory cytokines and chemokines, and its correlation with the disease severity, is not well defined. In this chapter, we report useful markers to identify lung infiltrating innate immune cells and define their activation status. We also describe a simple method to measure intracellular cytokine production to evaluate the inflammatory activity of neutrophils and IMMs in a mouse model of human coronavirus infection.

Entities:  

Keywords:  Coronavirus; Cytokines and chemokines; Inflammatory monocyte-macrophages; Lungs; Neutrophils

Mesh:

Substances:

Year:  2020        PMID: 31883097      PMCID: PMC7123665          DOI: 10.1007/978-1-0716-0211-9_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice.

Authors:  Yumi Hashimoto; Takeshi Moki; Takenori Takizawa; Akiko Shiratsuchi; Yoshinobu Nakanishi
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

Review 2.  Monocyte recruitment during infection and inflammation.

Authors:  Chao Shi; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2011-10-10       Impact factor: 53.106

3.  Neutrophils ameliorate lung injury and the development of severe disease during influenza infection.

Authors:  Michelle D Tate; Yi-Mo Deng; Jessica E Jones; Gary P Anderson; Andrew G Brooks; Patrick C Reading
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

Review 4.  The role of TLRs in neutrophil activation.

Authors:  Lynne R Prince; Moira K Whyte; Ian Sabroe; Lisa C Parker
Journal:  Curr Opin Pharmacol       Date:  2011-07-06       Impact factor: 5.547

5.  Pathogenic potential of interferon αβ in acute influenza infection.

Authors:  Sophia Davidson; Stefania Crotta; Teresa M McCabe; Andreas Wack
Journal:  Nat Commun       Date:  2014-05-21       Impact factor: 14.919

6.  Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice.

Authors:  Rudragouda Channappanavar; Anthony R Fehr; Rahul Vijay; Matthias Mack; Jincun Zhao; David K Meyerholz; Stanley Perlman
Journal:  Cell Host Microbe       Date:  2016-02-10       Impact factor: 21.023

Review 7.  A Role for Neutrophils in Viral Respiratory Disease.

Authors:  Jeremy V Camp; Colleen B Jonsson
Journal:  Front Immunol       Date:  2017-05-12       Impact factor: 7.561

8.  Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia.

Authors:  Katrin Högner; Thorsten Wolff; Stephan Pleschka; Stephanie Plog; Achim D Gruber; Ulrich Kalinke; Hans-Dieter Walmrath; Johannes Bodner; Stefan Gattenlöhner; Peter Lewe-Schlosser; Mikhail Matrosovich; Werner Seeger; Juergen Lohmeyer; Susanne Herold
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

9.  Type-I interferon is critical for FasL expression on lung cells to determine the severity of influenza.

Authors:  Daisuke Fujikura; Satoko Chiba; Daisuke Muramatsu; Mika Kazumata; Yosuke Nakayama; Taro Kawai; Shizuo Akira; Hiroshi Kida; Tadaaki Miyazaki
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

10.  Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.

Authors:  Lisa E Gralinski; Timothy P Sheahan; Thomas E Morrison; Vineet D Menachery; Kara Jensen; Sarah R Leist; Alan Whitmore; Mark T Heise; Ralph S Baric
Journal:  mBio       Date:  2018-10-09       Impact factor: 7.867

View more
  10 in total

Review 1.  Drug targets for COVID-19 therapeutics: Ongoing global efforts.

Authors:  Ambrish Saxena
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

2.  Immunoinformatics Identification of B- and T-Cell Epitopes in the RNA-Dependent RNA Polymerase of SARS-CoV-2.

Authors:  Niti Yashvardhini; Amit Kumar; Deepak Kumar Jha
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-04-20       Impact factor: 2.471

3.  Severe Acute Respiratory Syndrome Coronavirus 2-Induced Immune Activation and Death of Monocyte-Derived Human Macrophages and Dendritic Cells.

Authors:  Jian Zheng; Yuhang Wang; Kun Li; David K Meyerholz; Chantal Allamargot; Stanley Perlman
Journal:  J Infect Dis       Date:  2021-03-03       Impact factor: 5.226

Review 4.  Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn.

Authors:  Mehdi Shahgolzari; Afagh Yavari; Yaser Arjeini; Seyed Mohammad Miri; Amirhossein Darabi; Amir Sasan Mozaffari Nejad; Mohsen Keshavarz
Journal:  Gene Rep       Date:  2021-11-05

Review 5.  COVID 19: a clue from innate immunity.

Authors:  Domenico Birra; Maurizio Benucci; Luigi Landolfi; Anna Merchionda; Gabriella Loi; Patrizia Amato; Gaetano Licata; Luca Quartuccio; Massimo Triggiani; Paolo Moscato
Journal:  Immunol Res       Date:  2020-06       Impact factor: 4.505

6.  Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.

Authors:  Aaron Volk; Matthew Hackbart; Xufang Deng; Yazmin Cruz-Pulido; Amornrat O'Brien; Susan C Baker
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103

Review 7.  Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body.

Authors:  Asit Saha; Barsha Saha
Journal:  Rev Med Virol       Date:  2020-07-19       Impact factor: 11.043

Review 8.  The role of antigen-presenting cells in the pathogenesis of COVID-19.

Authors:  Rana Farzi; Parisa Shiri Aghbash; Narges Eslami; Arezou Azadi; Ali Shamekh; Nima Hemmat; Taher Entezari-Maleki; Hossein Bannazadeh Baghi
Journal:  Pathol Res Pract       Date:  2022-03-23       Impact factor: 3.309

Review 9.  Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.

Authors:  Joan T Merrill; Doruk Erkan; Jerald Winakur; Judith A James
Journal:  Nat Rev Rheumatol       Date:  2020-07-30       Impact factor: 20.543

10.  Roles of existing drug and drug targets for COVID-19 management.

Authors:  Akeberegn Gorems Ayele; Engidaw Fentahun Enyew; Zemene Demelash Kifle
Journal:  Metabol Open       Date:  2021-06-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.